联系客服

002644 深市 佛慈制药


首页 公告 佛慈制药:2023年半年度财务报告

佛慈制药:2023年半年度财务报告

公告日期:2023-08-03

佛慈制药:2023年半年度财务报告 PDF查看PDF原文

                                                                                  财务报告
        兰州佛慈制药股份有限公司

                财务报告

      (2023 年 1 月 1 日至 2023 年 6 月 30 日止)

      目 录                                    页 次

一、 财务报表

      合并资产负债表                            1-2

      母公司资产负债表                          3-4

      合并利润表                                5

      母公司利润表                              6

      合并现金流量表                            7

      母公司现金流量表                          8

      合并股东权益变动表                        9-10

      母公司股东权益变动表                    11-12

二、  财务报表附注                            13-90


                                                                                财务报告
              合并资产负债表

编制单位:兰州佛慈制药股份有限公司    2023 年 6 月 30 日      单位:人民币元

          项      目                  附注五  2023 年 6 月 30 日  2022 年 12 月 31 日

流动资产:

 货币资金                                        (一)      336,079,651.82      396,452,956.90

 交易性金融资产                                                      2,001,578.08

 衍生金融资产
 应收票据

 应收账款                                        (二)      413,915,594.18      389,571,402.83

 应收款项融资                                  (三)      39,001,909.55      51,004,784.39

 预付款项                                        (四)      53,186,708.06      23,155,483.99

 其他应收款                                      (五)      42,462,250.92      62,811,870.59

 其中:应收利息
 应收股利

 存货                                              (六)      396,819,464.22      350,407,267.75

 合同资产
 持有待售资产
 一年内到期的非流动资产

 其他流动资产                                  (七)      15,960,048.91      15,662,811.90

          流动资产合计                      1,297,425,627.66    1,291,068,156.43

非流动资产:
 债权投资
 其他债权投资
 长期应收款

 长期股权投资                                  (八)      70,113,938.31      68,667,587.81

 其他权益工具投资
 其他非流动金融资产

 投资性房地产                                  (九)        8,271,199.30        8,534,792.50

 固定资产                                        (十)    1,047,260,622.81    1,065,595,014.12

 在建工程                                        (十一)      10,415,246.67

 生产性生物资产
 油气资产

 使用权资产                                    (十二)        861,837.45        1,205,350.82

 无形资产                                        (十三)      81,291,539.93      76,789,315.10

 开发支出

 商誉                                              (十四)      4,472,232.85        4,472,232.85

 长期待摊费用                                  (十五)      9,801,836.00        6,000,420.26

 递延所得税资产                              (十六)      50,431,215.15      52,360,185.43

 其他非流动资产                              (十七)      17,356,346.27      11,875,793.09

        非流动资产合计                      1,300,276,014.74    1,295,500,691.98

            资产总计                        2,597,701,642.40    2,586,568,848.41

 公司负责人:石爱国  主管会计工作负责人:岳金风  会计机构负责人:王婷


              合并资产负债表(续)

编制单位:兰州佛慈制药股份有限公司  2023 年 6 月 30 日            单位:人民币元

          项      目                  附注五  2023 年 6 月 30 日  2022 年 12 月 31 日

流动负债:

  短期借款                                        (十八)      10,000,000.00

  交易性金融负债

  衍生金融负债

  应付票据                                        (十九)        4,597,604.70        2,300,965.00

  应付账款                                        (二十)      351,357,521.71      308,744,299.78

  预收款项

  合同负债                                        (二十一)      35,877,175.61      94,745,894.40

  应付职工薪酬                                  (二十二)      1,852,669.86        2,186,900.81

  应交税费                                        (二十三)      29,185,996.05      69,425,185.01

  其他应付款                                    (二十四)      75,760,432.08      31,002,778.05

    其中:应付利息

        应付股利

  持有待售负债

  一年内到期的非流动负债                  (二十五)      14,082,207.63      13,838,874.29

  其他流动负债                                  (二十六)      4,179,692.20        8,241,329.40

          流动负债合计                          526,893,299.84      530,486,226.74

非流动负债:

  长期借款                                        (二十七)      5,660,000.00

  应付债券

    其中:优先股

        永续债

  租赁负债                                        (二十八)        347,707.28          530,971.16

  长期应付款                                    (二十九)      26,600,000.00      40,366,193.34

  长期应付职工薪酬

  预计负债

  递延收益                                        (三十)      269,512,846.18      278,150,018.68

  递延所得税负债                                    2,856,672.09        3,062,177.70

  其他非流动负债

        非流动负债合计                          304,977,225.55      322,109,360.88

            负债合计                            831,870,525.39      852,595,587.62

股东权益:

  股本                                              (三十一)    510,657,000.00      510,657,000.00

  其他权益工具

    其中:优先股

        永续债

  资本公积                                        (三十二)    343,511,317.07      343,511,317.07

  减:库存股

  其他综合收益                                  (三十三)          99,745.75          73,596.17

  专项储备                                        (三十四)      1,523,800.35        1,523,800.35

  盈余公积                          
[点击查看PDF原文]